Cell Therapy for Liver Disease Using Bioimaging Rats

Area of Science:

• Regenerative Medicine
• Hepatology
• Cell Therapy

Background:

• Cell therapy is emerging as a potential alternative to liver transplantation for various liver diseases.
• Minimally invasive and individualized cell therapies are sought to minimize rejection and patient burden.
• Mesenchymal stem cells (MSCs) are increasingly explored for liver cirrhosis treatment, shifting from traditional bone marrow transplantation (BMT).

Purpose of the Study:

• To provide an overview of cell transplantation research for liver disease using rat models.
• To evaluate the efficacy of different cell types and transplantation methods in preclinical liver disease models.
• To highlight the role of bioimaging in assessing in vivo cell kinetics and therapeutic effects.

Main Methods:

• Development of various rat imaging models for liver disease.
• Transplantation of bone marrow cells (BMCs) and MSCs via the portal vein (PV) in acute and chronic liver damage models.
• Utilizing genetically modified rats (Alb-DsRed2, luc-Tg, GFP Tg) for cell tracking and assessment of therapeutic outcomes.

Main Results:

• Transplanted BMCs increased in number and size in acute and chronic liver damage models.
• Hepatocyte transplantation in hepatectomized rats showed sustained luminescence for 2 months.
• Repeated BMT via PV reduced liver fibrosis, and MSCs inhibited apoptosis while promoting regeneration.

Conclusions:

• Cell transplantation, particularly with MSCs, demonstrates therapeutic potential for liver diseases.
• Bioimaging techniques in rats are invaluable for observing transplanted cell behavior and evaluating therapy effectiveness.
• Optimizing cell number and delivery methods is critical for successful clinical translation of cell therapies for liver disease.